News
Shares of vaccine makers saw an uptick in the latest trading session, with Moderna Inc (BMV:MRNA). (NASDAQ:MRNA) leading the ...
The agency now projects Vistra's adjusted debt/EBITDA to show a more gradual improvement, declining to 6.2x in 2025 and further to 5.8x in 2026, from 6.8x in 2024. Its adjusted EBITA/interest is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback